MariTide demonstrated up to ~20% average weight loss in the obesity group after 52 weeks
Introduction Dipeptidyl peptidase 4 (DPP4) enzyme is a type II transmembrane glycoprotein, expressed ubiquitously in many tissues, including the immune cells, kidney, liver, pancreas, fat cells, and presents as a soluble form in the circulation [1]
o Do not store the Pen with the needle attached
& Study 1821 Investigators 2016 A Phase 2, randomized, dose-finding study of the novel once-weekly human GLP-1 analog, semaglutide, compared with placebo and open-label liraglutide in patients with type 2 diabetes
"Historically, obesity treatment was frustrating for both doctors and patients because the effects were minimal and very often, patients would lose weight temporarily and weight regain was common." Several specialists echoed Dr Ng's view
The last time the company traded at a sub-20 P/E was in 2019